Lowering serum lipid levels is part of the foundation of treating and preventing clinically
significant cardiovascular disease. Recently, the American Heart Association/American
College of Cardiology released cholesterol guidelines which advocate for high efficacy
statins rather than LDL-c goals for five patient subgroups at high risk for cardiovascular
disease. Therefore, it is critical that clinicians have an approach for managing side-effects of
statin therapy. Statins are associated with myopathy, transaminase elevations, and an …